Accelerating Cancer Drug Discovery Through Structural Biology (3rd scientific meeting)

This event has been postponed.

Further information will be available here in due course.

Including -

Keynote Speaker:

Stefan Knapp, SGC node at the Goethe-University Frankfurt

and a full programme of speakers  -

  • Small Molecular Drug Discovery Case Studies: Peter Cherepanov (Chromatin structure and mobile DNA Laboratory, Crick) Nuska Tschammer (Subject Matter Expert, Wuxi/Crelux)
  • Biologics: Alastair Lawson (Senior Fellow, UCB); Svend Kjaer (Structural Biology, Science Technology Platform Deputy, Crick), David Matthews (Associate Director Biotherapeutics, LifeArc)
  • Emerging Technologies: Aude Echalier-Glazer (Scientific Coordinator, Exscientia); Jose Marquez (Head of the Crystallization Facility, EMBL Grenoble), Martin Noble (Professor of Biomolecular Structure and Anticancer Drug Design)
  • Short presentations and posters from researchers.

This free one-day meeting is open to anyone with an interest in the use of structural biology and fragment-based hit screening to accelerate drug discovery in oncology and beyond.

16th March 2020, The Francis Crick Institute, London, #AcceleratingCancerDrugDiscovery

Enquiries to Anna Harding,

Made possible thanks to generous support from:

CRUK logo CRICK logo Mitegen Peak Proteins

NanotempertechSwissci logo WuXI




Novel coronavirus (2019-nCoV) and visitor access to the Crick

At the Crick we are carefully monitoring the spread of novel coronavirus (2019-nCoV), and are putting measures in place to minimise the risk to anyone who is working at the Crick or visiting us.

Please read the information on our website which aligns with advice from Public Health England.

If you are feeling well and haven’t visited the places listed then we very much look forward to seeing you on the 16 March for a busy day of drug discovery research.

Share this page: